BSG and hepatocellular carcinoma: Metuximab is a mouse monoclonal antibody fragment, HAb18F (ab’) 2, which can bind to HAbl8G/CD147, a highly expressed antigen on the surface of hepatocellular carcinoma cells, and block specific signal transduction to induce apoptosis of tumor cells.